NCT02231424View on ClinicalTrials.gov

Postmarketing Surveillance Study of Berodual® Metered-dose Inhaler in Chronic Obstructive Airways Disease

CompletedOBSERVATIONAL
Enrollment

713

Participants

Timeline

Start Date

January 31, 1999

Primary Completion Date

November 30, 1999

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Drug: Berodual®

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY